RecruitingNot Applicable

Multi-modal Quantitative Imaging of the Skin

Sweden8,000 participantsStarted 2023-02-01

Plain-language summary

This clinical trial is about evaluating the suitability of multi-modal imaging technology, which covers virtually the entire body, to evaluate the possibility of screening and early detection of disease.

Who can participate

Age range

18 Years

Sex

ALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria: * Adult patients that are part of the regular healthcare patient flow at the investigational sites, or as separately invited to participate in this investigation. * Patients with signed informed consent Exclusion criteria: * Cognitive impairment * Patients unable to understand the oral and written study information in Swedish or English * Other severe disorder or terminal disease * Patients unable to provide an informed consent * Patients not able to keep balance, while standing up with closed eyes, without any aid * Claustrophobic patients

Questions worth asking your doctor

Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.

1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?

Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.

Questions for the trial coordinator

The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.

1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?

A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.

What they're measuring

Sensitivity for detection of lesions requiring excision in comparison to visual inspection

Timeframe: Typically same day as enrolment, or if follow-up then 1 year following enrolment.

Difference in body metrics between full-body 3D photography and traditional measurements

Timeframe: Typically same day as enrolment, or if follow-up then 1 year following enrolment.

Sensitivity in detection of dermatological conditions with 2D images from full-body photography

Timeframe: Typically same day as enrolment, or if follow-up then 1 year following enrolment.

Sensitivity in detection of new or significantly changed lesions, from macroscopic images using 2D and 3D full-body photography.

Timeframe: Typically same day as enrolment, or if follow-up then 1 year following enrolment.

Correlation between thermal gradient in hands and/or feet with diagnosis of peripheral arterial disease or Raynaud's phenomenon

Timeframe: Typically same day as enrolment, or if follow-up then 1 year following enrolment.

Trial details

NCT IDNCT06989216

SponsorHJN Sverige AB/Neko Health

Sponsor typeINDUSTRY

Study typeOBSERVATIONAL

Primary completion2026-02-01

Contact for this trial

Mattias Windå, MSc

0703169040 mattias@nekohealth.com

View on ClinicalTrials.gov More Skin Cancer trials